Real-world COVID-19 vaccine effectiveness in Zimbabwe: A test-negative case-control study
Résumé
Background: COVID-19 vaccination is critical in sub-Saharan Africa to reduce the disease burden. This study assessed real-world vaccine effectiveness (VE) in Zimbabwe. Aim: To determine COVID-19 VE and factors associated with disease severity and mortality in Zimbabwe. Setting: The study setting comprised a test-negative case-control study across health facilities in Harare and Bulawayo (May 2023 – August 2023). Methods: Adults (≥ 18 years) were recruited from COVID-19 registers (1:1 case-control; matched by sex, age and clinic visit date). Telephone interviews assessed vaccination status, disease severity (cases) and comorbidities. Conditional logistic regression estimated VE (1 – odds ratio*100), with stratification by age and comorbidities. Ordinal and simple logistic regression analysed factors associated with disease severity and vaccination–variant relationships. Results: Overall vaccination coverage was 38% (fully vaccinated including boosters), with 62% unvaccinated. The median age was 38 years (interquartile range [IQR]: 30–50) with more females (n = 352). Overall VE against any COVID-19 infection was 32.2% (95% CI: 8.9, 49.5). Older age (45+ years) and chronic conditions were associated with increased hospitalisation risk. Among cases, hospitalisation rate was 34.8% (n = 174/500) and COVID-19-related mortality rate was 11.6% (n = 58/500). Conclusion: This study found a moderate VE of COVID-19 vaccines in Zimbabwe, potentially influenced by age, comorbidities and variants. We highlight the need for targeted vaccination strategies and public health measures informed by these findings. Contribution: This research informs public health strategies to optimise vaccination efforts and improve health outcomes across Africa, aligning with the journal’s focus on public health issues.
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 28/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →